{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:57:58Z","timestamp":1793937478831,"version":"4.8.0"},"reference-count":222,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P42ES010337"],"award-info":[{"award-number":["P42ES010337"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1053\/j.gastro.2018.12.036","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T01:17:30Z","timestamp":1547774250000},"page":"1264-1281.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1393,"title":["Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease"],"prefix":"10.1053","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6715-8588","authenticated-orcid":false,"given":"Laurent","family":"Castera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireen","family":"Friedrich-Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2018.12.036_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib7","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib10","first-page":"e16","article-title":"EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, Update 2017 (Long Version)","volume":"38","author":"Dietrich","year":"2017","journal-title":"Eur J Ultrasound"},{"key":"10.1053\/j.gastro.2018.12.036_bib11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrgastro.2016.86","article-title":"Critical comparison of elastography methods to assess chronic liver disease","volume":"13","author":"Friedrich-Rust","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib12","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.ultrasmedbio.2018.07.008","article-title":"Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations","volume":"44","author":"Ferraioli","year":"2018","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-5926-4-10","article-title":"The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis","volume":"4","author":"Poynard","year":"2005","journal-title":"Comp Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2018.12.036_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-230X-10-98","article-title":"A\u00a0simple index of lipid overaccumulation is a good marker of liver steatosis","volume":"10","author":"Bedogni","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/jgh.12665","article-title":"Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Otgonsuren","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12072-016-9772-z","article-title":"Non-invasive diagnosis of hepatic steatosis","volume":"11","author":"Stern","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib20","doi-asserted-by":"crossref","first-page":"e30325","DOI":"10.1371\/journal.pone.0030325","article-title":"Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data","volume":"7","author":"Poynard","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.12.036_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-14-0112","article-title":"External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals","volume":"171","author":"Cuthbertson","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.gastro.2018.12.036_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.24356","article-title":"Fatty liver index and mortality: the Cremona study in the 15th year of follow-up","volume":"54","author":"Calori","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib25","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","article-title":"Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD","volume":"32","author":"Ballestri","year":"2012","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib26","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","author":"Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib27","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/liv.12840","article-title":"Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients","volume":"35","author":"Bril","year":"2015","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib28","doi-asserted-by":"crossref","first-page":"W168","DOI":"10.2214\/AJR.16.16726","article-title":"A\u00a0Pilot comparative study of quantitative ultrasound, conventional ultrasound, and MRI for predicting histology-determined steatosis grade in adult nonalcoholic fatty liver disease","volume":"208","author":"Paige","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.gastro.2018.12.036_bib29","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3748\/wjg.14.1415","article-title":"Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound","volume":"14","author":"de Moura Almeida","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1381\/096089204323093408","article-title":"The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients","volume":"14","author":"Mottin","year":"2004","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2018.12.036_bib31","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2014.11.027","article-title":"Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique","volume":"13","author":"Lin","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib32","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib33","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib35","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jgh.12557","article-title":"Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease","volume":"29","author":"Chan","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2050640616646528","article-title":"Controlled attenuation parameter using the FibroScan(R) XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population","volume":"5","author":"Chan","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2018.12.036_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/jgh.13219","article-title":"Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease","volume":"31","author":"de Ledinghen","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib38","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/j.ejrad.2011.10.029","article-title":"Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD","volume":"81","author":"Friedrich-Rust","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.gastro.2018.12.036_bib39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis\u00a0in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib40","doi-asserted-by":"crossref","first-page":"e91987","DOI":"10.1371\/journal.pone.0091987","article-title":"Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy","volume":"9","author":"Karlas","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib41","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/jgh.12134","article-title":"Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?","volume":"28","author":"Kumar","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib42","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/MEG.0000000000000919","article-title":"Controlled attenuation parameter for diagnosing steatosis in bariatric surgery candidates with suspected nonalcoholic fatty liver disease","volume":"29","author":"Naveau","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of\u00a0steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib44","first-page":"162931","article-title":"MR spectroscopy-derived proton density fat fraction is superior to controlled attenuation parameter for detecting and grading hepatic steatosis","author":"Runge","year":"2017","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty\u00a0liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib46","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s10620-017-4638-3","article-title":"Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan\u00ae. A Comparative Study with the M Probe and Liver Biopsy","volume":"62","author":"de Ledinghen","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2018.12.036_bib47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive\u00a0diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography","volume":"32","author":"de Ledinghen","year":"2012","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib48","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.dld.2017.03.013","article-title":"A\u00a0comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B","volume":"49","author":"Xu","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2018.12.036_bib49","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/ajg.2017.389","article-title":"Prognostic value of controlled attenuation parameter by transient elastography","volume":"112","author":"Liu","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib50","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2018.12.036_bib51","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1172\/JCI93465","article-title":"Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis","volume":"127","author":"Caussy","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2018.12.036_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.13405","article-title":"Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE","volume":"43","author":"Doycheva","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.12.036_bib53","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Heritability of hepatic fibrosis and steatosis based on a prospective twin study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib54","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib55","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.27647","article-title":"Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)","volume":"61","author":"Loomba","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhep.2016.04.021","article-title":"Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"65","author":"Cui","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib57","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.gastro.2017.06.005","article-title":"Agreement between magnetic resonance imaging proton density fat\u00a0fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis","volume":"153","author":"Middleton","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Non-invasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib60","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/1756283X16656735","article-title":"Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis","volume":"9","author":"Patel","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2018.09.024","article-title":"Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib","volume":"70","author":"Jayakumar","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2018.04.014","article-title":"Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty\u00a0liver disease","volume":"155","author":"Ajmera","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","article-title":"Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions","volume":"68","author":"Loomba","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib64","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib65","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib66","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cgh.2008.07.016","article-title":"Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients","volume":"6","author":"Diab","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib67","first-page":"347","article-title":"A\u00a0novel pathophysiological-based panel of biomarkers for the diagnosis of nonalcoholic steatohepatitis","volume":"63","author":"Grigorescu","year":"2012","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1053\/j.gastro.2018.12.036_bib68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.24734","article-title":"Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis","volume":"55","author":"Joka","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib69","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3945\/ajcn.111.015610","article-title":"Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis","volume":"94","author":"Musso","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2018.12.036_bib70","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/MCG.0b013e3181c0945a","article-title":"Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease","volume":"44","author":"Papatheodoridis","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib71","first-page":"772","article-title":"Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery","volume":"107","author":"Pirvulescu","year":"2012","journal-title":"Chirurgia (Bucur)"},{"key":"10.1053\/j.gastro.2018.12.036_bib72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In\u00a0vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib73","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3748\/wjg.v13.i6.837","article-title":"Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis","volume":"13","author":"Yilmaz","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib74","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s11695-008-9506-y","article-title":"A\u00a0novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)","volume":"18","author":"Younossi","year":"2008","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2018.12.036_bib75","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jhep.2011.12.025","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers","volume":"56","author":"Shen","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib76","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/apt.12569","article-title":"Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease\u2014the role of transient elastography and plasma cytokeratin-18 fragments","volume":"39","author":"Kwok","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.12.036_bib77","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"10.1053\/j.gastro.2018.12.036_bib78","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","article-title":"Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"Cusi","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib80","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2010.08.023","article-title":"An apoptosis panel for nonalcoholic steatohepatitis diagnosis","volume":"54","author":"Tamimi","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib81","doi-asserted-by":"crossref","first-page":"e0174394","DOI":"10.1371\/journal.pone.0174394","article-title":"Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib82","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11695-010-0204-1","article-title":"A\u00a0biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis","volume":"21","author":"Younossi","year":"2011","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2018.12.036_bib83","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1365-2036.2010.04480.x","article-title":"A\u00a0new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients","volume":"32","author":"Anty","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.12.036_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2005.01209.x","article-title":"Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease","volume":"26","author":"Palekar","year":"2006","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib86","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","article-title":"Nonalcoholic fatty liver disease in severely obese subjects","volume":"102","author":"Gholam","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib87","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.gastro.2018.12.036_bib88","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00535-010-0305-6","article-title":"A\u00a0simple clinical\u00a0scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease","volume":"46","author":"Sumida","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","article-title":"Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Poynard","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib90","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/hep.22241","article-title":"A\u00a0clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients","volume":"47","author":"Campos","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib91","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11695-010-0118-y","article-title":"A\u00a0noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients","volume":"20","author":"Ulitsky","year":"2010","journal-title":"Obes Surg"},{"key":"10.1053\/j.gastro.2018.12.036_bib92","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MEG.0b013e3283464111","article-title":"Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity","volume":"23","author":"Lassailly","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib93","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib94","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","article-title":"A\u00a0population-based study on the prevalence of NASH using scores\u00a0validated against liver histology","volume":"60","author":"Hyysalo","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib95","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cgh.2016.05.046","article-title":"Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites","volume":"14","author":"Zhou","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib96","doi-asserted-by":"crossref","first-page":"e0142661","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of Serum microRNAs -122, -192 and -21 as biomarkers in patients with non-alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib97","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty\u00a0liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.12.036_bib98","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiol.11101942","article-title":"Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography","volume":"259","author":"Chen","year":"2011","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib99","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.27362","article-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study","volume":"60","author":"Loomba","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/ajg.2016.65","article-title":"Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD: a prospective study","volume":"111","author":"Loomba","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib101","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ultrasmedbio.2016.01.026","article-title":"Diagnosis of clinically significant portal hypertension in patients with cirrhosis: splenic arterial resistive index versus liver stiffness measurement","volume":"42","author":"Lee","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib102","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0037-1618587","article-title":"Can elastography differentiate isolated fatty liver from nonalcoholic steatohepatitis?","volume":"38","author":"Ajmera","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2018.12.036_bib103","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-0035-1562948","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease","volume":"35","author":"Castera","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2018.12.036_bib104","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver\u00a0disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"},{"key":"10.1053\/j.gastro.2018.12.036_bib106","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib107","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease","volume":"65","author":"Boursier","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib108","article-title":"ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis","author":"Daniels","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib109","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1148\/radiol.2016160685","article-title":"Diagnostic performance of MR elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity","volume":"283","author":"Chen","year":"2017","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib111","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/liv.12584","article-title":"The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"35","author":"Petta","year":"2015","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib112","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ajg.2016.49","article-title":"The performance of vibration controlled transient elastography in a us cohort of patients with nonalcoholic fatty liver disease","volume":"111","author":"Tapper","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib113","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJM197810262991705","article-title":"Problems of spectrum and bias in evaluating the efficacy of diagnostic tests","volume":"299","author":"Ransohoff","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2018.12.036_bib114","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2018.12.036_bib115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/apt.14219","article-title":"Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD","volume":"46","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.12.036_bib116","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/j.1365-2893.2011.01537.x","article-title":"Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis","volume":"19","author":"Friedrich-Rust","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2018.12.036_bib117","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1007\/s00330-013-2927-6","article-title":"The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis","volume":"23","author":"Nierhoff","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1053\/j.gastro.2018.12.036_bib118","first-page":"309","article-title":"Comparative study between two point shear wave elastographic techniques: acoustic radiation force impulse (ARFI) elastography and ElastPQ","volume":"16","author":"Sporea","year":"2014","journal-title":"Med Ultrason"},{"key":"10.1053\/j.gastro.2018.12.036_bib119","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.28337","article-title":"Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study","volume":"63","author":"Cui","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib120","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ultrasmedbio.2013.04.019","article-title":"Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease","volume":"39","author":"Fierbinteanu Braticevici","year":"2013","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib121","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00330-012-2505-3","article-title":"Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging","volume":"22","author":"Guzman-Aroca","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1053\/j.gastro.2018.12.036_bib122","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2010.12.019","article-title":"Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease","volume":"55","author":"Palmeri","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib123","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.10091662","article-title":"Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography","volume":"256","author":"Yoneda","year":"2010","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib124","article-title":"Acoustic radiation force impulse elastography for the non-invasive evaluation of hepatic fibrosis in non-alcoholic fatty liver disease patients: a systematic review & meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib125","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.29179","article-title":"Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis","volume":"67","author":"Herrmann","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib126","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib127","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/liv.13284","article-title":"Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity","volume":"37","author":"Pavlides","year":"2017","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib128","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1148\/radiol.2017160622","article-title":"Distinguishing between hepatic inflammation and fibrosis with MR elastography","volume":"284","author":"Yin","year":"2017","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib129","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","article-title":"MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice","volume":"65","author":"Dulai","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/apt.13196","article-title":"Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study","volume":"41","author":"Cui","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.12.036_bib131","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.cgh.2017.10.037","article-title":"Association between obesity and discordance in fibrosis stage determination by magnetic resonance vs transient elastography in patients with nonalcoholic liver disease","volume":"16","author":"Caussy","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib132","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cgh.2018.05.059","article-title":"Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants","volume":"17","author":"Hsu","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib133","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/dc14-1239","article-title":"Clinical model for NASH and advanced fibrosis in adult\u00a0patients with diabetes and NAFLD: guidelines for\u00a0referral in NAFLD","volume":"38","author":"Bazick","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2018.12.036_bib134","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study","volume":"65","author":"Kwok","year":"2016","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.12.036_bib135","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/liv.13481","article-title":"Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan","volume":"37","author":"Roulot","year":"2017","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib136","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hep4.1208","article-title":"A\u00a0pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care","volume":"2","author":"Patel","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2018.12.036_bib137","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jim-2018-000864","article-title":"Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus","volume":"67","author":"Bril","year":"2019","journal-title":"J\u00a0Investig Med"},{"key":"10.1053\/j.gastro.2018.12.036_bib138","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/dom.13285","article-title":"Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"20","author":"Bril","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1053\/j.gastro.2018.12.036_bib139","article-title":"Elevated serum cytokeratin-18 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease","author":"Chang","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"10.1053\/j.gastro.2018.12.036_bib140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc17-1349","article-title":"Clinical and histologic characterization of nonalcoholic steatohepatitis in African American patients","volume":"41","author":"Bril","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2018.12.036_bib141","doi-asserted-by":"crossref","first-page":"e0160526","DOI":"10.1371\/journal.pone.0160526","article-title":"Influence of ethnicity on the accuracy of non-invasive scores predicting non-alcoholic fatty liver disease","volume":"11","author":"Xia","year":"2016","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib142","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"145","author":"Angulo","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib143","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib144","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","article-title":"Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a\u00a0systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib145","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3748\/wjg.v24.i15.1601","article-title":"Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity","volume":"24","author":"Pirola","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib146","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.gastro.2018.12.036_bib147","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1194\/jlr.P055640","article-title":"Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis","volume":"56","author":"Loomba","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1053\/j.gastro.2018.12.036_bib148","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib149","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/hep.28860","article-title":"Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood","volume":"65","author":"Decaris","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib150","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","article-title":"Metabolomic identification of subtypes of nonalcoholic steatohepatitis","volume":"152","author":"Alonso","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib151","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib152","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut Microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2018.12.036_bib153","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13658","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: non-invasive tests are enough","volume":"38","author":"Castera","year":"2018","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib154","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-10-40","article-title":"Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)","volume":"10","author":"Poynard","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.27981","article-title":"Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study","volume":"63","author":"Koehler","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib156","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gut.2010.221382","article-title":"Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years","volume":"60","author":"Roulot","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.12.036_bib157","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","article-title":"Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.12.036_bib158","doi-asserted-by":"crossref","first-page":"e007516","DOI":"10.1136\/bmjopen-2014-007516","article-title":"Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography","volume":"5","author":"Harman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1053\/j.gastro.2018.12.036_bib159","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2468-1253(16)30081-4","article-title":"Screening for liver fibrosis in the general population: a call for action","volume":"1","author":"Gines","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib160","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib161","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib162","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2018.12.036_bib163","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jhep.2008.07.035","article-title":"Comparison of blood tests for liver fibrosis specific or not to NAFLD","volume":"50","author":"Cales","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib164","doi-asserted-by":"crossref","first-page":"17041713","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib165","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1440-1746.2011.06774.x","article-title":"Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease","volume":"26","author":"Adams","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib166","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","article-title":"Liver fibrosis in\u00a0overweight patients","volume":"118","author":"Ratziu","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2018.12.036_bib167","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib168","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28843","article-title":"Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values","volume":"65","author":"Petta","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib170","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib171","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jhep.2007.11.020","article-title":"Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome","volume":"48","author":"Roulot","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib172","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib173","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.25993","article-title":"Determination of reliability criteria for liver stiffness evaluation by\u00a0transient elastography","volume":"57","author":"Boursier","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib174","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations","volume":"51","author":"Castera","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib176","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.29489","article-title":"Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease","volume":"67","author":"Vuppalanchi","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib177","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/ajg.2012.331","article-title":"Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease","volume":"107","author":"Wong","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib178","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","article-title":"Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases","volume":"14","author":"Coco","year":"2007","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2018.12.036_bib179","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.22056","article-title":"Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage","volume":"47","author":"Sagir","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.22007","article-title":"Acute viral hepatitis increases liver stiffness values measured by transient elastography","volume":"47","author":"Arena","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib181","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/hep.22577","article-title":"Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis","volume":"48","author":"Millonig","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib182","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jhep.2009.11.018","article-title":"Liver stiffness is directly influenced by central venous pressure","volume":"52","author":"Millonig","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib183","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1478-3231.2009.02100.x","article-title":"Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection","volume":"29","author":"Mederacke","year":"2009","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib184","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.26343","article-title":"Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution","volume":"58","author":"Arena","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib185","doi-asserted-by":"crossref","first-page":"e58742","DOI":"10.1371\/journal.pone.0058742","article-title":"Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension","volume":"8","author":"Berzigotti","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib186","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib187","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.27844","article-title":"The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib188","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28843","article-title":"Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values","volume":"65","author":"Petta","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib189","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib190","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/gut.2008.149708","article-title":"Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C","volume":"57","author":"Arena","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2018.12.036_bib191","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jhep.2010.06.022","article-title":"Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis","volume":"54","author":"Gaia","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib192","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib193","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ultrasmedbio.2015.08.008","article-title":"Liver steatosis assessed by controlled attenuation parameter (CAP) measured with the XL probe of the FibroScan: a pilot study assessing diagnostic accuracy","volume":"42","author":"Sasso","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib194","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s12072-014-9573-1","article-title":"Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis","volume":"8","author":"Ferraioli","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2018.12.036_bib195","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/MEG.0b013e32835f4c3d","article-title":"Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of\u00a0hepatic steatosis on the basis of transient elastography","volume":"25","author":"Recio","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib196","doi-asserted-by":"crossref","first-page":"e0173992","DOI":"10.1371\/journal.pone.0173992","article-title":"High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal","volume":"12","author":"Kjaergaard","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2018.12.036_bib197","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12876-017-0609-6","article-title":"The\u00a0inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography","volume":"17","author":"Ratchatasettakul","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2018.12.036_bib198","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","article-title":"Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations","volume":"60","author":"de Ledinghen","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib199","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2017.05.005","article-title":"Validity criteria for\u00a0the diagnosis of fatty liver by M probe-based controlled attenuation parameter","volume":"67","author":"Wong","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib200","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib201","first-page":"e16","article-title":"EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (Long Version)","volume":"38","author":"Dietrich","year":"2017","journal-title":"Eur J Ultrasound"},{"key":"10.1053\/j.gastro.2018.12.036_bib202","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ultrasmedbio.2015.03.007","article-title":"WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver","volume":"41","author":"Ferraioli","year":"2015","journal-title":"Ultrasound Med Biol"},{"key":"10.1053\/j.gastro.2018.12.036_bib203","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrgastro.2016.86","article-title":"Critical comparison of elastography methods to assess chronic liver disease","volume":"13","author":"Friedrich-Rust","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib204","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Non-invasive, quantitative assessment of liver fat by MRI-PDFF as an\u00a0endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2018.12.036_bib205","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","article-title":"MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice","volume":"65","author":"Dulai","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2018.12.036_bib206","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jmri.23741","article-title":"Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration","volume":"36","author":"Reeder","year":"2012","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1053\/j.gastro.2018.12.036_bib207","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiol.10100659","article-title":"Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T","volume":"258","author":"Yokoo","year":"2011","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1053\/j.gastro.2018.12.036_bib209","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1148\/radiol.2511080666","article-title":"Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T","volume":"251","author":"Yokoo","year":"2009","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.mri.2007.08.012","article-title":"Relaxation effects in the quantification of fat using gradient echo imaging","volume":"26","author":"Bydder","year":"2008","journal-title":"Magn Reson Imaging"},{"key":"10.1053\/j.gastro.2018.12.036_bib211","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.mri.2010.03.017","article-title":"Assessment of liver fat quantification in the presence of iron","volume":"28","author":"Bydder","year":"2010","journal-title":"Magn Reson Imaging"},{"key":"10.1053\/j.gastro.2018.12.036_bib212","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/mrm.21301","article-title":"Fat quantification with IDEAL gradient echo imaging: correction of bias\u00a0from T(1) and noise","volume":"58","author":"Liu","year":"2007","journal-title":"Magn Reson Med"},{"key":"10.1053\/j.gastro.2018.12.036_bib213","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/jmri.21751","article-title":"Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling","volume":"29","author":"Reeder","year":"2009","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1053\/j.gastro.2018.12.036_bib214","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/nbm.1622","article-title":"In\u00a0vivo characterization of the liver fat (1)H MR spectrum","volume":"24","author":"Hamilton","year":"2011","journal-title":"NMR Biomed"},{"key":"10.1053\/j.gastro.2018.12.036_bib215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1148\/radiol.2523081817","article-title":"Early detection of steatohepatitis in fatty rat liver by using MR elastography","volume":"253","author":"Salameh","year":"2009","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib216","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jmri.23731","article-title":"Magnetic resonance elastography of liver: technique, analysis, and clinical applications","volume":"37","author":"Venkatesh","year":"2013","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1053\/j.gastro.2018.12.036_bib217","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1053\/j.gastro.2018.12.036_bib218","doi-asserted-by":"crossref","first-page":"19339","DOI":"10.1038\/srep19339","article-title":"Reproducibility of intra- and inter-scanner measurements of liver fat using complex confounder-corrected chemical shift encoded MRI at 3.0 Tesla","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2018.12.036_bib219","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2017170550","article-title":"Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis","volume":"286","author":"Yokoo","year":"2018","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2036.2012.05121.x","article-title":"Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver\u00a0disease\u2014MRI accurately quantifies hepatic steatosis in NAFLD","volume":"36","author":"Permutt","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2018.12.036_bib221","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiol.11101942","article-title":"Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography","volume":"259","author":"Chen","year":"2011","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib222","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiol.2016160863","article-title":"Technical failure of MR elastography examinations of the liver: experience from a large single-center study","volume":"284","author":"Wagner","year":"2017","journal-title":"Radiology"},{"key":"10.1053\/j.gastro.2018.12.036_bib223","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1148\/radiol.2016160685","article-title":"Diagnostic performance of MR elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity","volume":"283","author":"Chen","year":"2017","journal-title":"Radiology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519300514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508519300514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:43:42Z","timestamp":1762163022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508519300514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":222,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0016508519300514"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2018.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the AGA Institute","name":"copyright","label":"Copyright"}]}}